Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cstone Pharmaceuticals (OP:CSPHF)

0.8003 +0.0974 (+13.86%)
Streaming Delayed Price Updated: 3:38 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cstone Pharmaceuticals

News headline image
Week In Review: Hengrui And Degron Announce $7.2 Billion In Drug Licensings ↗
Via Talk Markets
News headline image
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC ↗
Bliss Biopharma may out-license global rights for its HER2 ADC to Eisai Pharma in a deal with a potential value of $2 billion. Also, Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to Dr.... 
Via Talk Markets
News headline image
Pfizer's Cancer Drug Partner Mulls Sale: Report ↗
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.